This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Khan, S Articles by Zachariah, A Search for Related Content PubMed PubMed Citation Articles by Khan, S Articles by Zachariah, A Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Poisoning Social Bookmarking                         What's this?

Neuroparalysis and oxime efficacy in organophosphate poisoning: a study of butyryicholinesterase

Department of Medicine, Christian Medical College and Hospital, Vellore 632 004, Tamil Nadu, India; Neurochemistry Laboratory, Departmnent of Neurological Sciences, Christian Medical College and Hospital, Vellore 632 004, Tamil Nadu, India

R Hemalatha

L Jeyaseelan

Department of Biostatistics, Christian Medical College and Hospital, Vellore 632 004, Tamil Nadu, India

A Oommen

Neurochemistry Laboratory, Departmnent of Neurological Sciences, Christian Medical College and Hospital, Vellore 632 004, Tamil Nadu, India

A Zachariah

Department of Medicine, Christian Medical College and Hospital, Vellore 632 004, Tamil Nadu, India

The temporal profile of butyrylcholinesterase (BuChE) and in vitro pralidoxime-reactivated BuChE was studied in a cohort of 25 organophosphate-poisoned patients to examine their relationship to the development of intermediate syndrome and to understand reasons for lack of efficacy of oxime treatment. The clinical severity of poisoning (assessed by the Namba Scale) correlated significantly with the severity of intermediate syndrome. BuChE activity increased significantly over time and showed significant relationship to muscle power. The temporal profile of the enzyme was correlated to the clinical severity of poisoning. Reactivation potentials of BuChE (the difference between oxime-reactivated and-unreactivated enzyme activity) declined significantly with time after organophosphate ingestion. The reactivation potential of the enzyme at admission decreased significantly with increasing severity of poisoning and was lower in patients who developed intermediate syndrome. Patients who received oxime prior to hospitalization had a higher rate of intermediate syndrome and lower levels of BuChE at admission than those who had not. The study suggests that (i) BuChE reflects the clinical course of poisoning, confirming earlier studies; (ii) intermediate syndrome may be associated with a persistent inhibition of BuChE; and (iii) the lack of oxime efficacy in our patients maybe due to their severity of poisoning and the timing of oxime treatment.

Key Words: Butyrylcholinesterase • deliberate self-harm • intermediate syndrome • organophosphate poisoning • oxime

Human & Experimental Toxicology, Vol. 20, No. 4, 169-174 (2001)
DOI: 10.1191/096032701678766796


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. Eddleston, P. Eyer, F. Worek, M.H. Rezvi Sheriff, and N.A. Buckley Predicting outcome using butyrylcholinesterase activity in organophosphorus pesticide self-poisoning QJM, June 1, 2008; 101(6): 467 - 474. [Abstract] [Full Text] [PDF]

				M. Guven, M. Sungur, and B. Eser The effect of plasmapheresis on plasma cholinesterase levels in a patient with organophosphate poisoning Human and Experimental Toxicology, July 1, 2004; 23(7): 365 - 368. [Abstract] [PDF]